Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics
Authors
Keywords
-
Journal
Journal of Hepatocellular Carcinoma
Volume Volume 10, Issue -, Pages 1923-1933
Publisher
Informa UK Limited
Online
2023-11-01
DOI
10.2147/jhc.s428741
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment and Prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysis
- (2023) Dajana Glavas et al. JOURNAL OF GASTROINTESTINAL SURGERY
- The Current and Future State of AI Interpretation of Medical Images
- (2023) Pranav Rajpurkar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment
- (2023) Leonardo Da Fonseca et al. Molecular and Clinical Oncology
- Factors Influencing Overall Survival for Patients with Fibrolamellar Hepatocellular Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results Database
- (2022) Georgios Polychronidis et al. International Journal of General Medicine
- Computed Tomography Radiomics-Based Prediction of Microvascular Invasion in Hepatocellular Carcinoma
- (2022) Wenjun Yao et al. Frontiers in Medicine
- Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event
- (2022) Walaa Abdelhamed et al. World Journal of Gastrointestinal Oncology
- A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects
- (2022) Georgios Polychronidis et al. OncoTargets and Therapy
- Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma
- (2021) Yan Yang et al. Frontiers in Oncology
- Phase II Multicenter, Open‐Label Study of Oral ENMD‐2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma
- (2020) Ghassan K. Abou‐Alfa et al. ONCOLOGIST
- A Multicenter Randomized Three‐Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy ( EDT ) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma
- (2020) Imane El Dika et al. ONCOLOGIST
- Fibrolamellar carcinoma: Challenging the challenge
- (2020) Angela Lamarca et al. EUROPEAN JOURNAL OF CANCER
- Pretreatment tumor volume and tumor sphericity as prognostic factors in patients with oral cavity squamous cell carcinoma
- (2019) Achille Tarsitano et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT
- (2019) Xiaohong Ma et al. EUROPEAN RADIOLOGY
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- Is tumour sphericity an important prognostic factor in patients with lung cancer?
- (2019) Angela Davey et al. RADIOTHERAPY AND ONCOLOGY
- Radiomics with artificial intelligence: a practical guide for beginners
- (2019) Burak Kocak et al. Diagnostic and Interventional Radiology
- Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma
- (2017) Young-Joo Kim et al. HISTOPATHOLOGY
- Molecular testing for the clinical diagnosis of fibrolamellar carcinoma
- (2017) Rondell P Graham et al. MODERN PATHOLOGY
- Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma
- (2016) Suguru Yamashita et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Radiomics: Images Are More than Pictures, They Are Data
- (2016) Robert J. Gillies et al. RADIOLOGY
- Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments
- (2016) Woubet Tefera Kassahun World Journal of Surgical Oncology
- Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
- (2015) AL Chagas et al. Clinics
- Unique Genomic Profile of Fibrolamellar Hepatocellular Carcinoma
- (2015) Helena Cornella et al. GASTROENTEROLOGY
- Surgical treatment of fibrolamellar hepatocellular carcinoma: an underestimated malignant tumor?
- (2014) Paulo Herman et al. Hepatobiliary & Pancreatic Diseases International
- Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma
- (2014) J. N. Honeyman et al. SCIENCE
- Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma
- (2013) Ahmed O. Kaseb et al. ONCOLOGY
- A Systematic Review: Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma
- (2012) Michael N. Mavros et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Fibrolamellar hepatocellular carcinoma – Prolonged survival with multimodality therapy
- (2009) V. Maniaci et al. EJSO
- Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
- (2009) Sandrine Faivre et al. LANCET ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More